These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
617 related articles for article (PubMed ID: 19065083)
1. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Dougherty EJ Adv Skin Wound Care; 2008 Dec; 21(12):568-75. PubMed ID: 19065083 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context. Allenet B; Parée F; Lebrun T; Carr L; Posnett J; Martini J; Yvon C Diabetes Metab; 2000 Apr; 26(2):125-32. PubMed ID: 10804327 [TBL] [Abstract][Full Text] [Related]
3. Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series. Frykberg RG; Driver VR; Carman D; Lucero B; Borris-Hale C; Fylling CP; Rappl LM; Clausen PA Ostomy Wound Manage; 2010 Jun; 56(6):36-44. PubMed ID: 20567053 [TBL] [Abstract][Full Text] [Related]
4. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it]. Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451 [TBL] [Abstract][Full Text] [Related]
5. Platelet rich plasma for treatment of nonhealing diabetic foot ulcers: a case report. Mehrannia M; Vaezi M; Yousefshahi F; Rouhipour N Can J Diabetes; 2014 Feb; 38(1):5-8. PubMed ID: 24485205 [TBL] [Abstract][Full Text] [Related]
6. The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. de Leon JM; Driver VR; Fylling CP; Carter MJ; Anderson C; Wilson J; Dougherty RM; Fuston D; Trigilia D; Valenski V; Rappl LM Adv Skin Wound Care; 2011 Aug; 24(8):357-68. PubMed ID: 21768787 [TBL] [Abstract][Full Text] [Related]
7. A retrospective, longitudinal study to evaluate healing lower extremity wounds in patients with diabetes mellitus and ischemia using standard protocols of care and platelet-rich plasma gel in a Japanese wound care program. Sakata J; Sasaki S; Handa K; Uchino T; Sasaki T; Higashita R; Tsuno N; Hiyoshi T; Morimoto S; Rinoie C; Saito N Ostomy Wound Manage; 2012 Apr; 58(4):36-49. PubMed ID: 22466132 [TBL] [Abstract][Full Text] [Related]
8. The clinical and economic potential of hyperbaric oxygen therapy in the treatment of diabetic ulceration and other conditions. McMillan G; Glover M Int J Low Extrem Wounds; 2007 Sep; 6(3):130-8. PubMed ID: 17909170 [TBL] [Abstract][Full Text] [Related]
9. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a decision model for long-term outcomes. Vitale MG; Roye BD; Ruchelsman DE; Roye DP Spine J; 2007; 7(3):292-300. PubMed ID: 17482112 [TBL] [Abstract][Full Text] [Related]
10. Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): results of a phase 1/2 trial. Mulder G; Tallis AJ; Marshall VT; Mozingo D; Phillips L; Pierce GF; Chandler LA; Sosnowski BK Wound Repair Regen; 2009; 17(6):772-9. PubMed ID: 19821960 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Apligraf in the treatment of venous leg ulcers. Sibbald RG; Torrance GW; Walker V; Attard C; MacNeil P Ostomy Wound Manage; 2001 Aug; 47(8):36-46. PubMed ID: 11890002 [TBL] [Abstract][Full Text] [Related]
12. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus. Roe RH; Lass JH; Brown GC; Brown MM Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762 [TBL] [Abstract][Full Text] [Related]
13. [Dynamic changes of MMP-1, MMP-9 and TIMP-1 in the refractory diabetic dermal ulcers treated by autologous Platelet-rich gel]. He LP; Wang C; Chen DW; Li XJ; Ran XW Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):757-61. PubMed ID: 23230755 [TBL] [Abstract][Full Text] [Related]
14. Pilot trial of biovance collagen-based wound covering for diabetic ulcers. Letendre S; LaPorta G; O'Donnell E; Dempsey J; Leonard K Adv Skin Wound Care; 2009 Apr; 22(4):161-6. PubMed ID: 19325275 [TBL] [Abstract][Full Text] [Related]
15. Protocol for treatment of diabetic foot ulcers. Brem H; Sheehan P; Boulton AJ Am J Surg; 2004 May; 187(5A):1S-10S. PubMed ID: 15147985 [TBL] [Abstract][Full Text] [Related]
16. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. McCallon SK; Knight CA; Valiulus JP; Cunningham MW; McCulloch JM; Farinas LP Ostomy Wound Manage; 2000 Aug; 46(8):28-32, 34. PubMed ID: 11189545 [TBL] [Abstract][Full Text] [Related]
18. Practical considerations of using topical honey for neuropathic diabetic foot ulcers: a review. Eddy JJ; Gideonsen MD; Mack GP WMJ; 2008 Jul; 107(4):187-90. PubMed ID: 18702435 [TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Driver VR; Hanft J; Fylling CP; Beriou JM; Ostomy Wound Manage; 2006 Jun; 52(6):68-70, 72, 74 passim. PubMed ID: 16799184 [TBL] [Abstract][Full Text] [Related]
20. Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers. Ahmed M; Reffat SA; Hassan A; Eskander F Ann Vasc Surg; 2017 Jan; 38():206-211. PubMed ID: 27522981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]